TGF-β signaling in CAFs promotes the creation of physical and molecular barriers, which exclude CTLs from penetrating tumor nests and accessing cancer cells, thereby limiting effective anti-tumor immune responses[57,58]. This evidence concerns the gene TGFB1 and cancer.